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Mutations in PARK2, encoding Parkin, cause an autosomal recessive form of juvenile
Parkinson Disease (JPD). The aim of the present study was to investigate the impact of
PARK2 mutations on mitochondrial function and morphology in human skin fibroblasts.
We analyzed cells obtained from four patients clinically characterized by JPD, harboring
recessive mutations in PARK2. By quantitative PCR we found a reduction (<50%) of
PARK2 transcript in all patients but one; however Western Blot analysis demonstrated
the virtual absence of Parkin protein in all mutant fibroblasts. Respiration assays
showed an increment of oxygen consumption, which was uncoupled to ATP cellular
levels. This finding was probably due to presence of altered mitochondrial membrane
potential (19m), confirmed by JC-1 analysis. Themitochondrial network was comparable
between mutant and control cells but, interestingly, a “chain-like” network was found only
in mutant fibroblasts. Dissipation of 19m usually leads to mitochondrial fragmentation
in healthy cells and eventually to mitophagy; however, this behavior was not observed
in patients’ fibroblasts. The absence of mitochondrial fragmentation in mutant Parkin
fibroblasts could results in accumulation of damaged mitochondria not targeted to
mitophagy. This condition should increase the oxidative stress and lead to cellular
dysfunction and death. Our results suggest that PARK2 mutations cause mitochondrial
impairment, in particular reduction in ATP cellular levels and alteration of 19m, even
in non-neuronal cells and confirm the hypothesis that Parkin holds a pivotal role in
pro-fission events.
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Introduction
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Although its
etiology is mainly elusive, it has been shown that some substances with toxic effect on mito-
chondrial functioning (e.g., MPTP and rotenone) can induce parkinsonism in human and animal
model (Langston et al., 1983; Nicklas et al., 1985), suggesting an important role of mitochondria
in the pathophysiology of PD. Nevertheless, even if environment factors play an important role in
PD, mutations in a number of genes have been found to cause inherited forms of PD, with both
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autosomal dominant (e.g., LRRK2, SNCA) and recessive trans-
mission (e.g., PARK2, PINK1, DJ1). Many of these PD gene-
products have also been proven to influence mitochondrial
bioenergetics and dynamics, including membrane potential, res-
piratory activity, cristae structure, calcium homeostasis, mito-
chondrial DNA (mtDNA) integrity and clearance of dysfunc-
tional mitochondria (reviewed in Sai et al., 2012).
Mutations in PARK2, encoding Parkin, are the most frequent
cause of juvenile PD (JPD), accounting for up to 50% of the
cases with an age of onset<40 years (Kitada et al., 1998). PARK2
mutations range from single base pair substitutions, splice site
mutations and small nucleotide deletions, to large deletions or
duplications of one or more PARK2 exons; albeit through dif-
ferent mechanisms, all these variants probably have a “loss of
function” effect.
Parkin is amultifunctional E3Ubiquitin ligase, which is able to
perform a variety of ubiquitin linkages associated with numerous
cellular functions. To date, more than 30 putative substrates have
been reported and Parkin regulates their activity through both
degradative and non degradative ubiquitination (reviewed in
Dawson and Dawson, 2010). Several studies have highlighted for
Parkin a pivotal role inmitochondrial homeostasis and dynamics.
In association with PINK1, Parkin acts in mitochondrial fission
and fusion, mitochondrial transport and removal of damaged
mitochondria through mitophagy process (Narendra et al., 2008;
Wang et al., 2011; Yu et al., 2011; Ashrafi et al., 2014; Cook et al.,
2014). The triggering mechanism of PINK1/Parkin-dependent
mitophagy is the loss of mitochondrial transmembrane poten-
tial (19m). A remodeling mechanism of mitochondrial network
aiming at isolating damaged organelles from remaining healthy
mitochondria and detaching them from cytoskeletal elements
(Twig et al., 2008; Chan et al., 2011; Wang et al., 2011; Frank
et al., 2012) is necessary to ensure that only damaged mito-
chondria are removed, and precedes mitophagy. A recent study
of Buhlman et al. (2014) has demonstrated how Parkin may
promote mitochondrial division by a mechanism that is depen-
dent from Drp1, a GTPase that regulates mitochondrial fission,
but seems independent from PINK1 activity and probably, also,
not a prerogative for mitochondrial clearance. These findings
collectively demonstrate that Parkin is intimately involved in
preventing mitochondrial dysfunction.
Till now the studies performed on PARK2 mutant fibrob-
lasts in order to explore the impact of Parkin on mitochon-
drial functionality, have remain elusive (Mortiboys et al., 2008;
Grünewald et al., 2010; Pacelli et al., 2011; van der Merwe
et al., 2014); however these reports highlighted how fibroblasts
derived from PD patients may be a reliable model system to
study mitochondrial dysfunction. We report here that Parkin-
mutant fibroblasts derived from PD patients showed alterations
in mitochondrial bioenergetics, in particular reduction in ATP
cellular levels, decrease of 19m and probably impairment in
mitochondrial fission. These data suggest that PARK2 mutations
cause mitochondrial dysfunction even in non-neuronal cells con-
firming that skin fibroblasts from PARK2 mutant patients may
be a suitable system to gain further details on cellular dys-
function underlying PD and possibly to test new therapeutic
approaches.
Materials and Methods
The study was approved by the ethics committee of the Fon-
dazione IRCCS (Istituto di Ricovero e Cura a Carattere Scien-
tifico) Istituto Neurologico “Carlo Besta” and all individuals gave
written, informed consent.
Genetic Studies
Genotyping was performed by direct DNA sequencing of all
PARK2 exons and intron-exon boundaries, and using the MLPA
dosage kits (salsa MLPA kit P051-B1and P052-C1, MRC Hol-
land) covering all exons of PARK2. The protocol used was per
manufacturer’s instructions. Phenotypic and genotypic data of
PD patients and controls are summarized in Table 1.
RNA Extraction, PCR, and Real Time PCR
Analysis
Total mRNA was extracted from fibroblasts (80% confluence)
using the RNeasy Mini Kit (Qiagen) according to the manu-
facture’s protocol. RNA quantity was measured with the Nan-
odrop instruments (Nanodrop Technologies) and RNA integrity
was verified through gel electrophoresis. One microgram of
RNA was reverse-transcribed into cDNA by GoScript Reverse
Transcriptase protocol (Promega). PARK2 transcript was ampli-
fied using PCR with specific primers on PARK2 5′ and 3′
untranslated regions (UTRs). Primers sequences are as fol-
lows: PARK2 Fw 5′-GAGAGCCGCTGGTGGGAG-3′; Rc 5′-AA
GTCCAACTACAGCCAAATTG-3′.
PARK2 expression in cDNA samples was determined
using quantitative PCR with specific amplicons and
SYBR-green chemistry (GoTaq qPCR Master Mix, Promega);
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used
for normalization. Primer sequences are as follows:
PARK2 (nucleotides 1138-1212) Fw 5′-CTGCGACACCACC
ACAG-3′; Rc 5′-TGGATTGCACTTGAATCTGTG-3′
PARK2 (nucleotides 1246-1338), Fw 5′-TGACCAGAGGAA
AGTCACCTG-3′; Rc 5′-TCTTTACATTCCCGGCAGAA-3′;
GAPDH, Fw 5′-CTCTGCTCCTCCTGTTCGAC-3′; Rc 5′-AC
GACCAAATCCGTTGA-3′.
Skin Fibroblasts and Culture Condition
Skin biopsies were taken from patients and four healthy con-
trols following standard clinical procedure. Skin fibroblasts were
grown at 37◦C under 5% CO2 humidified atmosphere in F14
(EuroClone) medium supplemented with 10% FBS (EuroClone),
4% L-Glutamine and 2% penicillin/streptomycin, 1.5% Glucose,
1% Insulin, 0.1% FGF, 0.1% EGF. Five days before the experi-
ment the growth medium was changed to EMEM (EuroClone)
supplemented with 10% FBS (EuroClone), 4% L-Glutamine and
2% penicillin/streptomycin. The cells used in present studies were
between passages 7 and 12.
Measurement of Oxygen Consumption and
Extracellular Acidification Rates
Measurements of endogenous respiration rates in intact cell
were performed through SeaHorse XF96 Analyzer (Seahorse
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TABLE 1 | Genotypic and phenotypic characterization of investigated
individuals.
Code Sex Age of
onset
(year)
Mutation Clinical
status
DNA Protein
Mutants Pt1 F 35 c.714C>G
c.823C>T
p.C238W
p.R275W
Affected
Pt2 M 41 c.101_102delAG
c.101_102delAG
p.Q34R*5
p.Q34R*5
Affected
Pt3 F 37 Deletion ex1
c.823C>T
No
transcript/protein
p.R275W
Affected
Pt4 F 14 Duplication ex2
Deletion ex3-4-5
No
transcript/protein
p.N58_A206del
Affected
Controls Ct1 F / None Unaffected
Ct2 F / None Unaffected
Ct3 M / None Unaffected
Ct4 F / None Unaffected
Refseqs used: NM_004562.2 (for DNA), NP_004553.2 (for protein). Exon (ex) deletion and
duplication at DNA level were detected by MLPA dosage kits.
Bioscience). Cells are seeded at 20,000 cells/well in a 96-well
SeaHorse culture plate and leave to adhere overnight. Growth
medium was replaced with non-buffered DMEM and the plate
was incubated at 37◦Cwithout CO2 for 30min before starting the
assay. Oxygen consumption (OCR) was measured under basal
condition (OCR-B), after injection of oligomycin, an inhibitor of
complex V (OCR-O), and after addition of the uncoupling agent
FCCP, carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone
(OCR-F). A representative trace of the OCR measurements was
reported in Supplementary Figure S1. The readout of cellular res-
piration in different conditions can be used to define bioenergetic
parameters, such as the maximal respiration rate (MRR) (Inv-
ernizzi et al., 2012). MRR, index of electronic chain transport
efficiency, corresponds to OCR-F minus OCR-B.
The instrument also measures the extracellular acidification
rate (ECAR).
The detailed protocol was as follows:
Calibration/equilibration, 2 cycle: 1′ mixing
3′ waiting
Basal, 4 cycle: 5′ mixing
4′ recording (OCR-B and
ECAR)
Oligomycin injection, 4 cycle: 5′ mixing
4′ recording (OCR-O)
FCCP injection, 5 cycle: 5′ mixing
4′ recording (OCR-F)
All values were normalized by means of cell counts performed
through CyQuant Direct cell proliferation Assay kit (Invitrogen).
ATP Measurements
ATP levels were determined using the ATPlite Assay kit
(PerkinElmer). This method is based on mono-oxygenation of
luciferin, catalyzed by luciferase in the presence of Mg2+, ATP,
and oxygen, resulting in a luminescent signal that is proportional
to the ATP.
Fibroblasts were seeded in 96-well culture plates at count of
20,000 cells per individual. Luminescence was measured using a
multilabel plate reader (PerkinElmer). Values were normalized by
means of cell counts performed through CyQuant Direct cell pro-
liferation Assay kit (Invitrogen) according to the manufacturer’s
protocol.
Mitochondrial Network and Membrane Potential
Analysis
Twenty thousand cells were seeded in 35mm dish (Microtech)
(70% confluence) and leave to adhere overnight. Mitochondrial
morphology was assessed after cell staining with 10 nM Mito-
tracker CMX-Red (Invitrogen) for 30min at 37◦C. Fluorescence
was visualized with a digital imaging system using an inverted
microscope (Nikon, Japan). Images were captured with a Photo-
metrics Cascade CCD camera system (Crisel) and analyzed with
Metamorph acquisition/analysis software. The network mor-
phology was assessed by Metamorph analysis: cells with shape
factor ≥ 0.650 were classified as fragmented network, cells with
shape factor<0.650 as tubular network.
Detection of altered mitochondrial membrane potential was
performed using 5,5′,6,6′-tetrachloro-1,1′,3,3′ tetraethylbenzim-
idazolylcarbocyanine iodide (JC-1) staining kit (Sigma, CS0390)
according to manufacturer’s instruction.
Western Blot Analysis
Approximately 1 × 106 fibroblasts were trypsinized, centrifuged
at 1200 rpm for 5min, and solubilized in 200µl of RIPA buffer
(50mM Tris-HCl [pH 7.5], 150mM NaCl, 1% NP40, 0.5%
NaDOC, 5mM EDTA) with 1 × Complete Mini Protease
Inhibitor Cocktail Tablets (Roche) for 40min at 4◦C. Thirty
micrograms of proteins were used for each sample in denaturing
sodium-dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE). Immunoblot analysis was performed with the
ECL-chemiluminescence kit (Amersham) according to the man-
ufacturer’s protocol. A rabbit polyclonal anti-Parkin antibody
was used at 1:700 dilution (Cell Signaling); a mouse monoclonal
anti-Vinculin was used at 1:1000 dilution (Sigma). Secondary
anti-rabbit and anti-mouse were used at 1:5000 and 1:3000,
respectively.
Statistical Analysis
For individual experiments, data obtained were calculated as the
mean of the replicates ± standard deviation (SD) and then data
were compared using One-Way ANOVA followed by Tukey test
(vassarstat.net). Although the measurements obtained from the
replicates for each sample were relatively consistent in individual
experiments, the values may vary in different experiments per-
formed in different days. For this reason, we transformed each
value of OCR, ECAR, OCR/ECAR ratio, MRR, and ATP concen-
tration, into standard (z) scores, in order tomake the data of three
different experiments comparable with each other and perform
statistical analysis to the entire collection of experimental values
(Invernizzi et al., 2012).
For evaluation of mitochondrial potential and network analy-
sis Chi2-Pearson test was used to compare controls and mutants.
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Results
Fibroblasts Derived from Patients with Mutations
in PARK2 have Reduced Level of PARK2 mRNA
and Parkin Protein Compared to Controls
To examine the possible effect of PARK2 mutations on splic-
ing, a PCR amplification was performed on mRNA extracted
from patients’ fibroblasts. The full-length transcript was observed
for Pt1, Pt2, Pt3 mutant fibroblasts, whereas a shorter tran-
script, corresponding to a PARK2 isoform lacking exon 3-4-5
(sequence data not shown), was observed in Pt4 (Figure 1A).
Subsequently a quantitative PCR was performed. Pt2, Pt3, and
Pt4 showed a significantly decrease of PARK2 transcript less
than 50%, while Pt1, carrying two missense mutations, pre-
sented an amount of transcript similar to controls (Figure 1B).
However, by Western blotting analysis Parkin protein was
significantly reduced in all samples including Pt1; this sug-
gested instability of Parkin species with missense changes
(Figures 1C,D).
Oxygen Consumption is Increased in
PARK2-Mutant Fibroblasts and Not Correlated to
ATP Cellular Levels
In order to investigate mitochondrial bioenergetics status,
we evaluated respiration and extracellular acidification by
microscale oxyghraphy. We consistently observed a signifi-
cant increment of oxygen consumption (basal OCR-B) in all
mutant samples respect to controls (Figure 2A). Also the ratio
OCR/ECAR was higher in mutant respect to controls whereas
ECAR data was comparable between controls and mutant cells
(Supplementary Figures S2A,B), indicating that metabolism of
mutant cells did not shift toward glycolysis and that oxygen
consumption alteration was directly linked to electron transfer
chain activity. Similarly, MRR which is an index of electronic
chain transport efficiency, was higher than controls in all mutant
fibroblasts, except for Pt3 (Figure 2B). These findings indicated
that mutant cells forced the activity of the respiratory chain in
order to produce energy.
Then, we investigated the ATP content. Despite the increased
respiratory parameters, we observed a significant reduction of
ATP cellular levels in all mutant fibroblasts suggesting that
oxygen consumption was uncoupled to ATP cellular biosyn-
thesis (Figure 2C). We verify the dependence of oxygen con-
sumption on ATP synthase activity, evaluating the difference
between OCR in basal condition (OCR-B) and after com-
plex V block (OCR-O). In mutant samples, except for Pt1,
these values were lower than controls (Figure 2D). This result
reflects reduced sensitivity to oligomycin (Supplementary Fig-
ure S2C) and suggests that mutant fibroblasts had uncoupled
mitochondria.
FIGURE 1 | mRNA and protein levels of Parkin. (A) PCR amplification
on cDNA obtained from mRNA extracted from patients (Pt) and control
(Ct) fibroblasts, using primers in the 5′ and 3′-UTRs PARK2 regions. The
band corresponding to full-length transcript was present in Ct, Pt1, Pt2,
and Pt3. A shorter transcript was amplified from Pt4, and sequence
analysis showed that it corresponds to a PARK2 isoform lacking exons
3-4-5. (B) Quantitative PCR analysis of PARK2 transcript in controls (Ct)
and mutant fibroblasts (Pt) normalized to GAPDH. The controls’ mean is
set equal to 100%. Data were from two independent experiments
performed in duplicate. The amount of PARK2 transcript in Pt1 was
similar to controls, whereas in the other mutant fibroblasts transcript
levels are decreased (∼40% in Pt2, ∼25% in Pt3%, ∼50% in Pt4). (C)
Western blot analysis using whole-cell lysates from control and mutant
fibroblasts. Protein levels of Parkin were estimated using an antibody
able to recognize the C-terminus of protein. Vinculin was used as
loading control. (D) Densitometric analysis of Parkin levels normalized to
Vinculin, obtained from three independent western blot experiments. The
controls’ mean is set equal to 100%. Strongly reduced levels of Parkin
were detected in mutant fibroblasts; ∼20% in Pt1, ∼10% in Pt2 and
Pt3, <5% in Pt4.
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FIGURE 2 | Mitochondrial function. (A–D) The z-score values (dots) for
basal oxygen consumption (OCR-B), maximal respiration rate (MRR), ATP
amount, OCR-B minus OCR-O, are shown for control and mutant
fibroblasts. Three independent experiments, each with 16 replicates, were
performed. One-Way ANOVA followed by Tukey test was used (controls
vs. mutant). (A) Mutant fibroblasts exhibited a significant increment of
oxygen consumption. Pt1: p < 0.01 vs. Ct1,Ct2,Ct3,Ct4. Pt2: p < 0.05
vs. Ct1; p < 0.01 vs. Ct3. Pt3: p < 0.05 vs. Ct1; p < 0.01 vs. Ct3, Ct4.
Pt4: p < 0.05 vs. Ct1, Ct4; p < 0.01 vs. Ct3. (B) With the exception of
Pt3, mutant cells showed a higher MRR. Pt1, Pt2, Pt4: p < 0.01 vs. each
Ct. (C) Analysis of ATP cellular levels showed a significant reduction in all
mutant fibroblasts respect to controls. Pt1, Pt2, Pt4: p < 0.01 vs. each
Ct; Pt3: p < 0.05 vs. Ct1, Ct2; p < 0.01 vs. Ct3, Ct4. (D) The difference
between OCR-B and OCR-O has a trend toward reduction in mutant
fibroblasts respect to controls. Pt1: p < 0.05 vs. Ct4; Pt2, Pt3, Pt4:
p < 0.05 vs. Ct1, Ct2, Ct4.
Mutant Fibroblasts Showed Altered
Mitochondrial Membrane Potential Not
Associated with Mitochondrial Fragmentation
To evaluate the mitochondrial membrane potential we used JC-
1 staining. Cells with high mitochondrial membrane potential
promote the formation of red fluorescent JC-1 aggregates, while
cells with low membrane potential show a diffuse green fluo-
rescence. As shown in Figure 3 the vast majority of the fibrob-
lasts derived from controls showed a clear red fluorescence
(Figures 3A–C), while we observed a diffuse green fluorescence
(Figures 3D–F) in a great percentage of mutant PARK2 fibrob-
lasts (Figure 3J) indicating the presence of altered mitochondrial
membrane potential. To validate the assay, we treated controls
fibroblasts with uncoupling agent FCCP to induce 19m loss; as
expected, treated fibroblasts displayed green fluorescent signals,
whereas untreated fibroblasts showed red fluorescent aggregates
(Figures 3G–I and in Figure 3J).
We next visualized the mitochondrial networks by Mito-
tracker Red, a mitochondrion specific dye. First we determined
the form factor of cells by MetaMorph analysis, classifying the
cells into two groups: fragmented network (Figures 4A–C), or
tubular network (Figures 4B–D). This morphological assessment
showed no difference between mutant and control individuals
under basal condition (Figure 4E). However, we observed a pecu-
liar network with “chain-like” structure (Figures 4F,G) virtually
only in mutant fibroblasts.
Discussion
Several reports suggesting a connection between (dys)function of
Parkin and mitochondria quality control have been published.
However, the use of cellular models based on overexpression of
Parkin or its partners, and the presence of recombinant tagged
proteins, could have introduced bias or artifacts in various stud-
ies (Burchell et al., 2012; Rakovic et al., 2013). To better define
the function of Parkin we use a physiological model, investi-
gating mitochondrial dysfunction in fibroblasts derived from
four patients characterized by JPD and carrying recessive PARK2
mutations. Till now the studies performed on PARK2 mutant
fibroblasts in order to explore the impact of Parkin on mito-
chondrial functionality, have remained vague. Despite the small
group of samples, we were able to analyse how heterogeneous
mutations likely affect mitochondrial homeostasis. We demon-
strated that PARK2 mutations present in our group of patients
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FIGURE 3 | Mitochondrial membrane potential (19m). (A–I) JC-1
staining on fibroblasts from controls (A–C), Pt4 (D–F) and controls treated
with the uncoupling agent FCCP (1µM, 10′) (G–I). Red fluorescence (C), sign
of preserved 19m, was observed in almost all non-treated controls, whereas
several mutant fibroblasts (E,F) as well as FCCP treated controls, displayed
green fluorescent signals, index of mitochondrial membrane depolarization
(H,I). Scale bar, 50µm. (J) Quantification of cells observed with green and red
fluorescence (expressed in percentage). Data were from three independent
experiments, each with 50 counted cells. Mutant fibroblasts (Pt1, Pt2, Pt3,
Pt4) presented a higher number of cells with green fluorescence (∼40–50%),
than controls (∼10%). Test Chi2-Pearson, Pt vs Ct; p: 2,49E-06 (Pt1); p:
2,83E-09 (Pt2); p: 1,37E-05 (Pt3); p: 1,21E-09 (Pt4). ∗∗∗p < 0.0001.
drastically reduced the Parkin protein levels, thereby giving us
Parkin knock-down or knock-out cellular models.
Previous studies reported mitochondrial respiratory chain
(MRC) complex I deficiency in leukocytes derived from patients
with PARK2 mutations (Müftüoglu et al., 2004), but similar
analyses on fibroblasts have resulted in contradictory outcomes
(Mortiboys et al., 2008; Grünewald et al., 2010). We tried to use
a more sensitive assay in a physiological condition, investigat-
ing cellular respiration on intact vital cells, since its rate depends
on the cumulative activities of the entire set of MRC com-
plexes (Steenweg et al., 2012). In Parkin-mutant fibroblasts MRR,
which indicated efficiency of electron transport chain, resulted
augmented or similar respect to controls suggesting absence of
defects in mitochondrial complexes, in agreement with previous
work of Grünewald and colleagues.We observed also a high basal
oxygen consumption, indicating elevated electron flow through
the respiratory chain with an expected increase of oxidative phos-
phorylation. The absence of acidification indicated there was
not a shift toward glycolytic metabolism. However, surprisingly,
we observed significantly reduced ATP cellular concentration
in Parkin-mutant fibroblasts (Grünewald et al., 2010; van der
Merwe et al., 2014) and, also, an independence of oxygen con-
sumption from the activity of complex V (ATP synthase). This
discrepancy suggested a loss of mitochondrial membrane poten-
tial, reflecting the loss of coupling between oxygen consumption
and ATP synthesis. Accordingly, in Parkin-mutant fibroblasts
even under basal conditions, we found an impairment of 19m,
a feature previously reported (Mortiboys et al., 2008; Grünewald
et al., 2010). The presence of uncoupled mitochondria impairs
ATP production, essential for cellular vitality; in addition, the
uncoupling can lead to elevated production of reactive oxygen
species (ROS), due to compromised mitochondrial antioxidant
mechanisms (Aon et al., 2010), with increased levels of oxidized
proteins and eventually cell death (Grünewald et al., 2010; Pacelli
et al., 2011). In order to prevent this oxidative damage, cells acti-
vate pathways able to selectively eliminate damaged mitochon-
dria (Lemasters, 2005; Frank et al., 2012). Several studies have
showed that Parkin plays a pivotal role in mitophagy through a
defined mechanism triggered by loss of 19m. To ensure that
only faulty mitochondria are removed, a mitochondrial fission
process precedes mitophagy, permitting the isolation of dam-
aged organelles from remaining healthy network (Twig et al.,
2008; Chan et al., 2011; Wang et al., 2011). Different studies on
human cells also demonstrated an impact of Parkin mutations
on mitochondrial network and fission/fusion dynamics but the
results are still debated. Parkin mutant cells were found to be
comparable to controls (Grünewald et al., 2010; van der Merwe
et al., 2014) or more prone to enter fusion with increase in
mitochondrial branching (Mortiboys et al., 2008); only in one
study fragmented mitochondrial network was observed (Pacelli
et al., 2011). In agreement with previous works (Grünewald
et al., 2010; van der Merwe et al., 2014) we detected no sig-
nificant difference in mitochondrial network between Parkin-
mutant and control fibroblasts in spite of the presence of altered
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FIGURE 4 | Mitochondrial network. (A–D) Mitotracker Red staining from
controls (A, B) and mutant Pt1 (C, D). Representative images of cells
presenting fragmented or tubular network are shown. Scale bar, 50µm. (E)
Graphic representation of cells from control and patients, with fragmented or
tubular network. The network morphology was assessed by Metamorph
analysis: cells with shape factor ≥0.650 were classified as fragmented
network, cells with shape factor <0.650 as tubular network. Data were from
three independent experiments, each with 50 counted cells. No difference on
mitochondrial network was observed between mutant fibroblasts (Pt1, Pt2,
Pt3, Pt4) and controls (Ct). Test Chi2-Pearson (Pt vs Ct) was performed and
resulted not-significant for all mutant fibroblasts; p: 0,10 (Pt1); p: 0,72 (Pt2);
p: 0,59 (Pt3); p: 0,97 (Pt4). (F) Mitotracker Red staining showing a peculiar
mitochondrial “chain-like” network (arrow), observed virtually only in mutant
fibroblasts. Scale bar, 100µm. (G) Quantification of cells with “chain-like”
structure after Mitotracker Red staining. Data were from three independent
experiments, each with 50 counted cells. Test Chi2-Pearson (Pt vs. Ct); p:
1,83E-16 (Pt1); p: 2,56E-07 (Pt2); p: 7,46E-09 (Pt3); p: 0,008 (Pt4).
∗∗∗p < 0.0001; ∗p < 0.01.
mitochondrial potential. Our results suggest that in absence of
Parkin mitochondrial fission is partly impaired implying that
damaged mitochondria might injury the remaining intact net-
work. According to several publications ascribing Parkin a role in
promotion of mitochondrial removal after mitochondrial depo-
larization, an impairment of Parkin functionality could affect
Parkin/PINK1 dependent mitophagy, thus implying the accu-
mulation of damaged mitochondria (Figure 5). Interestingly, we
observed a “chain like” network only in Parkin mutant fibrob-
lasts. This data could indicate that, because of altered mitochon-
drial membrane potential, the fission mechanism was initialized
but, in absence of Parkin, was not concluded, suggesting that
Parkin plays a role in a late-stage of fission process. In agree-
ment with our results, Parkin has been recently shown to act on
mitochondrial fission protein Drp1, promoting Drp1-dependent
mitochondrial fission by a mechanism that seems to be inde-
pendent from PINK1 (Buhlman et al., 2014). Considering our
results and the abovementioned article (Buhlman et al., 2014), we
hypothesize that mutations in Parkin, and hence an impairment
of its activity, impact not only directly on mitophagy but can
also affect the physiological regulation of mitochondrial dynam-
ics. Recent evidences suggest that mitochondrial dynamics can
regulate mitochondrial activity and augmented fusion of mito-
chondrial network increase respiratory activity (MacVicar and
Lane, 2014; Mishra et al., 2014). We speculate that, in absence of
Parkin, mitochondria are forced to stay in a “fuse” state, with high
respiration rate but uncoupled to ATP production and associated
with altered19m; this may produce increase of ROS with subse-
quently damage to mitochondria (Figure 5). The limited number
of analyzed patients requires confirmatory studies.
However, our study confirms that PARK2 mutations lead
to mitochondrial impairment, in particular reduction in ATP
cellular levels and alteration of 19m, even in non-neuronal
cells in agreement with previous studies (Mortiboys et al., 2008;
Grünewald et al., 2010; van derMerwe et al., 2014). Further inves-
tigation of the relationship between Parkin and mitochondrial
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FIGURE 5 | Schematic view of the hypothetical connections between
PARK2 mutations and impairment of mitochondrial functions. PARK2
mutations impair Parkin functionality and linked pathways, like mitophagy and
fission process. Dysfunction in Parkin may interfere in both these pathways
implying an accumulation of damaged mitochondria, with ATP loss. Mutations
in PARK2 may also compromise the physiological mitochondrial fission
process. This implies that mitochondria are forced to stay in a fuse state, with
high respiration rate and impaired membrane potential (19m), causing ROS
increase and subsequently damage to mitochondria. These events create a
vicious circle where not only the physiological damaged mitochondria were not
removed but, in absence of Parkin, also newly synthesized mitochondria are
more likely prone to accumulate damages.
dynamics/mitophagy is warranted. Indeed, this study provides
that skin fibroblasts from PARK2 mutant patients may be a suit-
able system to study mitochondrial dysfunction in PD and to test
new therapeutic approaches based on rescue of mitochondrial
phenotypes.
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